# Ozempic's Therapeutic Outcomes on Obesity and Hypertension
This project explores the market impact of Ozempic and its therapeutic outcomes in treating obesity and hypertension. The analysis evaluates the effectiveness of Ozempic in improving patient recovery, identifying key variables that influence these outcomes. A comprehensive exploratory data analysis (EDA) and predictive modeling have been conducted, revealing significant variations in insurance reimbursements across states and demographics. These findings present opportunities for targeted business strategies and underscore the importance of data-driven decision-making in healthcare delivery. The project also highlights potential avenues for Novo Nordisk to advocate for equitable healthcare policies and develop patient support programs, reinforcing the critical role of analytics in pharmaceutical innovation.
